However, our data suggests that suppression of inflammation by targeting Stat4, in both immune cells and neurons, may be a method for preventing, or even reversing, the loss of LTP observed in AD and other neurodegenerative diseases associated with impairments in cognitive function. The gene discussed is STAT4; the disease is neurodegenerative disease.